Cited by — Reply to Martorell Calatayud et al., “Cost-Consequence Analysis of Secukinumab vs Adalimumab in Moderate-to-Severe Hidradenitis Suppurativa” | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Reply to Martorell Calatayud et al., “Cost-Consequence Analysis of Secukinumab vs Adalimumab in Moderate-to-Severe Hidradenitis Suppurativa”.
No admitted local citation edges point to this work yet.
